Poland· PL-100382091
Rekovelle
A follitropin delta product containing folitropinum delta, registered in Poland by Ferring Pharmaceuticals A/S. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Follitropin delta is registered in 12 of 19 countries.
Countries holding a registration under ATC G03GA10 (follitropin delta), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Follitropin delta · ATC G03GA10
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Folitropinum delta
- Manufacturer
- Ferring Pharmaceuticals A/S
- Country
- Poland (PL)
- ATC code
- G03GA10
- ATC class
- Follitropin delta
- Defined daily dose
- 12 mcg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991309275
- gtin05909991343026
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Follitropin delta in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainREKOVELLE 12 MICROGRAMOS/0,36 ML SOLUCIÓN INYECTABLEFerring Pharmaceuticals A/S
- BelgiumRekovelle 12 µg/0.36 mlFerring Pharmaceuticals
- SwedenREKOVELLE 12 mikrogram/0,36 mL Injektionsvätska, lösningFerring Pharmaceuticals A/S
- NorwayRekovelleFerring Pharmaceuticals A/S
- SwitzerlandRekovelle Pen 12 µg/0.36 ml, Injektionslösung im FertigpenFerring AG
- CzechiaREKOVELLEFerring Pharmaceuticals A/S, Kastrup
- United KingdomRekovelle 12micrograms/0.36ml solution for injection cartridgesFerring Pharmaceuticals Ltd
- FinlandREKOVELLEFerring Pharmaceuticals A/S
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rekovelle
- Liechtenstein · Rekovelle
- Norway · Rekovelle
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/387b2705-9b44-4860-91c2-1308f608d000 GET /v1/drugs/387b2705-9b44-4860-91c2-1308f608d000?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "36 mcg/1,08 ml",
"packaging": "05909991309275 ¦ Rpz ¦ Skasowane ¦ EU/1/16/1150/002 ¦ 119521\n1 wkład 1,08 ml + 6 igieł\n05909991343026 ¦ Rpz ¦ EU/1/16/1150/005 ¦ 124137\n1 wstrzykiwacz 1,08 ml ¦ 9 igieł",
"substance": "Folitropinum delta 36 mcg/1,08 ml",
"common_name": "Folitropinum delta",
"pl_product_id": "100382091",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about follitropin delta.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.